Real Time Screeners Intraday Screeners now on Real Time Data (Updated every 5 mins)
Stock Listing : A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z 

Stock Analysis of Ipca Laboratories , Birds-Eye-view On Returns/Technicals/Funda/F&O

About Strength Screener

Charts Of Ipca Laboratories Ltd.

1D   1W   2W   1M   3M   1Y   2Y   5Y   
Interactive Charts

Price / Volume Action

CodeIPCALAB
EOD Share Price1602.75
Previous Share Price1616.4
Price Change -13.65
Change % -0.844%
Volume1862.31 K
Five Day Avg Vol1634.15 K
Beta0.701875
Last Business Date09-Apr-20

Price Gain/Loss

DurationAbsolute ChgChg %
One Week 205.00 14.67
Two Weeks 312.95 24.26
One Month 139.30 9.52
Three Months 406.80 34.01
Six Months 738.60 85.47
One Year 666.60 71.21

Highs / Lows

DurationHighLow
One Week1825.01380.0
Two Weeks1825.01232.0
One Month1825.01200.0
Three Months1825.01163.9
Six Months1825.0844.65
One Year1825.0844.65

Key Moving Average

MA SMAEMA
5 Days 1505.721523.3
15 Days 1381.81426.33
20 Days 1370.851409.45
50 Days 1352.681348.47
100 Days 1253.791264.18
200 Days 1102.511147.41
Detailed MA Analysis of IPCALAB ...

Key Technical Indicators

MACD 46.77
RSI 73.21
RSI (Smooth) 67.34
ADX 31.67
Chaikin Money Flow -0.209
Williams %R -35.56
PSAR 1262.79
Detailed Tech Analysis IPCALAB ...

Financial Data Highlights

Market Cap19273.44
Book Value/ Share269.631
Enterprise Value3525.52
Revenue TTM4456.34
Gross Profit TTM2415.21
Revenue /Share TTM352.95
Consensus Target727.17
Key Financial Highlights IPCALAB ...

Financial Ratios of IPCALAB

EPS49.00
PE27.51
Div/Share8.00
Div Yield0.580
Trailing PE27.51
Forward PE0
Price/Book5.01
Key Financial Ratios of IPCALAB ...

Key Profit & Loss Data

Period31_Dec_2019Growth
Net Inc 0 100.00 %
Ops Income0 100.00 %
Revenue0 100.00 %
Ops Expense0 100.00 %
PBT0 100.00 %
Gross Profit0 100.00 %
Div Paid0 100.00 %
Key P&L IPCALAB ...

Price Range (PR) /Volatility

PeriodAvg PR Range %
LBD PR174.0010.86
Week PR384.9024.01
Month PR458.0028.58
5 Day Period157.1910.36
10 Day Period127.519.14
5 Week Period324.0125.29
3 Months Period440.0034.34
Price Range /Volatility IPCALAB ...

Highlights & Chart Patterns of Ipca Laboratories Ltd.

Share has hit 52 Week high on 08-Apr-20 (Yesterday).
Stock has jumped by more than 10% in last two weeks from its lowest level of 1232.0 dt 27-Mar-20
Stock has jumped by more than 15% in last One Month from its lowest level of 1200.0 dt 19-Mar-20.
Stock has jumped by more than 25% in last three Month from its lowest level of 1163.9 dt 04-Feb-20.
Stock has jumped by more than 50% in last Six Month from its lowest level of 844.65 dt 10-Oct-19.
Stock has fallen by more than 10% in last two weeks from its highest level of 1825.0 dt 08-Apr-20.
Bearish engulfing Candlestick pattern was formed by Ipca Laboratories Ltd. on 09/04/2020 Prior to pattern formation this share was in uptrend.
More Chart Patterns Ipca Laboratories Ltd. ...
You can now customize Equity with technical , SMA , Fin Data, chart patterns in one Page. Click here to view guide

Share Price History of Ipca Laboratories Ltd.

Date Open High Low Close Volume
09-Apr-20 1724.00 1724.00 1550.00 1602.75 1862 K
08-Apr-20 1609.50 1825.00 1580.00 1616.40 2802 K
07-Apr-20 1599.90 1599.90 1440.10 1526.15 2379 K
03-Apr-20 1413.45 1429.95 1380.00 1385.55 290 K
01-Apr-20 1380.00 1456.15 1367.00 1397.75 835 K
31-Mar-20 1341.00 1415.65 1313.50 1392.25 885 K
30-Mar-20 1245.00 1320.00 1245.00 1296.75 490 K
27-Mar-20 1341.00 1349.00 1232.00 1245.05 339 K
26-Mar-20 1315.00 1369.00 1233.45 1289.80 815 K
25-Mar-20 1352.00 1365.85 1281.15 1309.30 405 K
About Ipca Laboratories Limited
Ipca Laboratories Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India. The company offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, non- steroidal anti-inflammatory drugs, and anthelmintic. It also provides generic and branded formulations in the therapeutic segments, including anti-diabetic, anti-infective, anti-malarial, anti-parasitic, hemostatic, cardiac, DMARDs, derma, gastro intestinal, urological, hepatoprotective, steroid, biological, neuro psychiatry, ophthalmology, pain, respiratory, and anti-allergic, as well as nutritional in various dosage forms comprising oral solids and liquids, dry powders for suspension, and liquid and dry injectable. The company markets its products through a network of wholesalers, and sales and marketing personnel. It also exports its products to approximately 100 countries worldwide. Ipca Laboratories Ltd. has an agreement with Medicines for Malaria Venture to develop a novel antimalarial co-formulation named Atoguanil. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.
About Strength

Strength is based on Deep Analysis, Back Testing and Historical Trend Analysis using Machine Learning. Overall Technical Strength is based on 50+ indicators including Technicals, moving Avg, chart patterns, candlestick and proprietary algorithms.Technical Strength is currently calculated around around 5 to 6 PM. This is an automated process and in NO WAY should be considered as a tip as its based on past data. We strongly recommend to use these signals for information only and seek advise from a certified professional for any trading decision.If you like it then please share. The more the visitors the more the innovations. Feedback

We are working on fundamental strength also. Please share your views to help shape up the requirement.

( Intraday Analysis is on Real Time Data (Updated every 5 Mins). All Other analysis is based on End of Trade day's Value. Expected time of update is between 5 to 5.30 PM exchange time Zone)


All Rights Reserved By Mintnovate Market Research Pvt Ltd.